How much does Wegovy or Zepbound actually cost?

List prices for both drugs run over $1,000 a month. What you pay depends on your insurance, which savings program you qualify for, and where you fill the prescription. |---|---| | Commercial insurance with coverage + savings card | As low as $25/month (eligible patients) | Details not currently verified — check NovoCare | | No insurance coverage (self-pay Journey Program) | $299–$449/month depending on dose | Not currently verified — contact pharmacy directly | | Full cash pay, no savings program | Varies by pharmacy; close to list price | Varies by pharmacy; close to list price | Where Wegovy data is marked unverified, that reflects a genuine gap in available information at the time of publication, not an assumption that programs don't exist.

A note on all figures in this article: Prices and program terms change, sometimes without much public notice. Do not rely on any figure you read online, including here, without confirming it is still current with your insurer, pharmacist, or the manufacturer directly.

"List price," also called the wholesale acquisition cost, is what a manufacturer sets before insurance negotiation, rebates, or discounts are applied. It is rarely what a patient pays at the pharmacy counter. Zepbound is available across a range of doses. Lilly's self-pay Journey Program (described below) offers a useful proxy for dose-based pricing: $299 per month for lower doses (2.5 mg and 5 mg) and up to $449 per month for higher doses (7.5 mg through 15 mg). The full list price before any savings program is higher than these figures. Wegovy list price figures are not available from confirmed sources at the time this article was written. For current pricing, contact your pharmacy directly or visit Novo Nordisk's NovoCare program at novocare.com.

Having insurance that covers a drug is not the same as having a low, predictable copay. Coverage means the drug appears on your plan's formulary, the list of medications your insurer has agreed to pay toward. What you actually owe depends on several additional factors.

Formulary tier

Specialty drugs like Wegovy and Zepbound are often placed on higher tiers, which carry higher copays or coinsurance percentages.

Prior authorization

Your prescribing clinician typically must submit documentation showing the medication is medically necessary and that you meet the plan's criteria, which may include a specific BMI threshold or a weight-related health condition.

Step therapy

Some plans require you to try a different medication before they will approve coverage for Wegovy or Zepbound.

Deductible status

If you haven't met your annual deductible, you may owe the full negotiated price, not a flat copay, until you do.

For Zepbound, eligible commercially insured patients can reduce their out-of-pocket cost to as low as $25 per month through Lilly's savings program, which applies to up to a 3-month prescription supply. Eligibility requirements apply. For Wegovy, the NovoCare savings program may offer cost assistance for commercially insured patients, but current program details could not be verified at the time of publication. Visit novocare.com for current information. The only way to know your actual cost is to contact your insurer directly and ask for a specific out-of-pocket estimate for your plan.

Manufacturer savings programs, sometimes called copay cards, reduce the cost-sharing burden for commercially insured patients. They cover some or all of what your insurance plan would otherwise require you to pay. They are not patient assistance programs for people without insurance; a separate type of program applies in that case.

Zepbound: commercially insured patients

Lilly's savings program can reduce monthly out-of-pocket costs to as low as $25 for eligible commercially insured patients, applied to up to a 3-month supply per prescription. Confirm your eligibility directly with Lilly or with your pharmacist at the point of sale.

Zepbound: self-pay / Journey Program

For patients whose insurance does not cover Zepbound, or who are uninsured, Lilly offers the Journey Program with tiered pricing based on dose:

$299 per month for lower doses (2.5 mg and 5 mg)

Up to $449 per month for higher doses (7.5 mg through 15 mg)

This is a lower-cost alternative to paying close to list price, though it remains a significant monthly expense for many people.

Wegovy: savings program

Current details of the NovoCare savings program for Wegovy could not be verified from confirmed sources at the time this article was written. Visit novocare.com directly for current program details.

Who is excluded from both programs

Patients covered by Medicare, Medicaid, or other government-funded insurance are explicitly excluded from both Lilly's and Novo Nordisk's manufacturer savings programs. This is a hard eligibility requirement, not a case-by-case determination.

Without insurance and without a manufacturer savings program, you will pay close to the list price. Cash prices vary by pharmacy and by region. The only reliable way to know what you would pay is to call your specific pharmacy and ask for a cash price quote for the exact drug, dose, and supply you need. Discount tools like GoodRx may offer some reduction from the cash price, but they typically do not bring costs close to what manufacturer savings programs offer. It is worth checking, but do not assume a discount tool will make these medications affordable without insurance. Compounded versions of semaglutide and tirzepatide have been available at lower prices through compounding pharmacies. That topic carries distinct regulatory and safety considerations that fall outside the scope of this article. We note it only so readers know it exists as a category; we are not endorsing or recommending compounded medications.

Your insurer, clinician, and pharmacist can each give you information specific to your situation.

Ask your insurer or HR benefits team:

Is Wegovy or Zepbound on my formulary, and at what tier?

Do I need prior authorization, and what criteria must be met?

Is there a step therapy requirement?

What is my cost-sharing after my deductible is met?

Ask your prescribing clinician:

Which drug is being prescribed, and does that choice affect my coverage?

Can you document medical necessity in a way that supports prior authorization?

If one drug isn't covered, is the other?

Ask your pharmacist:

What is the cash price for this specific drug and dose?

Am I eligible for the manufacturer savings card, and can you run it at the point of sale?

Is a 90-day supply cheaper per month than a 30-day supply under my plan or savings program?

Wegovy pricing and savings program details could not be verified from current confirmed sources at the time of writing. Check NovoCare directly for accurate, current information. Out-of-pocket costs for insured patients are inherently variable and cannot be predicted without knowing your specific plan, deductible status, and formulary tier. Medicare and Medicaid coverage are not addressed here. Those programs have distinct and evolving rules, and manufacturer savings programs explicitly exclude their beneficiaries. Prices and program terms change. This article reflects information available at publication and should not substitute for a current pharmacy quote or direct verification with your insurer or the manufacturer.